---
title: "Xtandi (enzalutamide), all indications: Access and coverage questions"
description: "Access and coverage questions on Xtandi (enzalutamide) that apply to every indication, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Topics: Access support, Cost and coverage, Prior authorization, and Patient support. Questions: Is Xtandi dispensed through a specialty pharmacy? How can patients without prescription drug coverage get Xtandi? Is Xtandi covered by Medicare Part D? Do most Medicare and commercial patients have parity or preferred access to Xtandi? 18 further questions follow. 22 questions quoted from 6 sources."
canonical: "https://www.evicenter.com/medical-information/xtandi/access-and-coverage"
published: "2026-11-14T01:54:55-05:00"
modified: "2026-11-14T15:19:23-05:00"
---

# Xtandi (enzalutamide), all indications: Access and coverage questions

Manufacturer: Astellas Pharma US, Inc.; Pfizer Inc.  
Prescribing information: [Xtandi](https://www.astellas.us/docs/us/12A005-ENZ-WPI.pdf)  
Indication pages: [Castration-resistant prostate cancer](https://www.evicenter.com/medical-information/xtandi--castration-resistant-prostate-cancer)

## Access support

<a id="xtandi-specialty-pharmacy"></a>

### Is Xtandi dispensed through a specialty pharmacy?

> “XTANDI prescriptions are filled only through specialty pharmacies in the XTANDI network or by dispensing physician practices.
>
> Specialty pharmacies typically mail the patient's prescription directly to the patient. There are also physician practices that may elect to dispense XTANDI through their in-office dispensing pharmacies.”

Source: [XTANDI: XTANDI® (enzalutamide) | Access and Support Resources, captured 2026-11-13](https://www.xtandihcp.com/support/access-support#:~:text=XTANDI%20prescriptions%20are%20filled%20only,through%20their%20in%2Doffice%20dispensing%20pharmacies.)

Note: The lists of network specialty pharmacies and specialty distributors on the access support page were not captured as text.

<a id="xtandi-no-drug-coverage"></a>

### How can patients without prescription drug coverage get Xtandi?

> “Option 1: Submit an XTANDI prescription directly to a specialty pharmacy or order XTANDI from a specialty distributor if you are a dispensing practice or hospital. See lists below.
>
> Applicable to most insured patients.
>
> Option 2: Request to access XTANDI through XTANDI Support Solutions®.*
>
> Applicable to patients without prescription drug benefits. Learn more about XTANDI Support Solutions*
>
> Please reach out with any questions by calling XTANDI Support Solutions* at 1-855-8XTANDI (1-855-898-2634). We are available Monday–Friday, 8:00 AM–8:00 PM ET.
>
> *XTANDI Support Solutions is a component of Astellas Pharma Support Solutions<sup>SM</sup>. Program terms and conditions apply.”

Source: [XTANDI: XTANDI® (enzalutamide) | Access and Support Resources, captured 2026-11-13](https://www.xtandihcp.com/support/access-support#:~:text=Option%201%3A%20Submit%20an%20XTANDI,Program%20terms%20and%20conditions%20apply.)

<a id="xtandi-samples-vouchers"></a>

### Are Xtandi samples or vouchers available for eligible patients?

> “Ask your XTANDI sales representative about available sampling and voucher programs for eligible patients.”

Source: [XTANDI: XTANDI® (enzalutamide), captured 2026-11-13](https://www.xtandihcp.com/dosing#:~:text=Ask%20your%20XTANDI%20sales%20representative,voucher%20programs%20for%20eligible%20patients.)

<a id="xtandi-copay-enrollment"></a>

### How do offices enroll a patient in the Xtandi copay program?

> “The XTANDI Patient Savings Program* is for eligible commercially insured patients taking XTANDI tablets.”

Source: [XTANDI: XTANDI® (enzalutamide) | Support Solutions, captured 2026-11-14](https://www.xtandihcp.com/support/xtandi-support-solutions#:~:text=The%20XTANDI%20Patient%20Savings%20Program%2A,insured%20patients%20taking%20XTANDI%20tablets.)

On the page, select: COST AND COPAY SUPPORT

> “HCPs can begin the Program enrollment process on behalf of their patients by following these steps:
>
> STEP 1:
> GO to XTANDIcopayenroll.com
> ENTER your patient's demographic information
> STEP 2:
> CONFIRM if you are the HCP or specialty pharmacy enrolling on behalf of your patient
> STEP 3:
> ANSWER questions to confirm your patient's eligibility, including their insurance status and place of residence
> STEP 4:
> ATTEST that you have shared the terms and conditions for the XTANDI Patient Savings Program with the patient. Confirm that the patient has consented to comply with such terms and conditions
> STEP 5:
> PRINT your patient's copay program processing information. If you are the HCP, please send this information to your patient's specialty pharmacy. If you are the specialty pharmacy, please save this information to your patient's records and process the copay program claim accordingly
> INFORM your patient that they will receive a copy of their copay program details via a mailed letter and email (if provided during enrollment)”

Source: [XTANDI: XTANDI® (enzalutamide) | Support Solutions, captured 2026-11-14](https://www.xtandihcp.com/support/xtandi-support-solutions#:~:text=HCPs%20can%20begin%20the%20Program,email%20%28if%20provided%20during%20enrollment%29)

On the page, select: COST AND COPAY SUPPORT

> “Please call us at 1-855-217-8311 for additional information or for help enrolling into the Program. We are available Monday–Friday, 8 AM–8 PM ET.”

Source: [XTANDI: XTANDI® (enzalutamide) | Support Solutions, captured 2026-11-14](https://www.xtandihcp.com/support/xtandi-support-solutions#:~:text=Please%20call%20us%20at%201%2D855%2D217%2D8311,Monday%E2%80%93Friday%2C%208%20AM%E2%80%938%20PM%20ET.)

On the page, select: COST AND COPAY SUPPORT

> “The Program is for eligible patients with commercial prescription insurance coverage for XTANDI® (enzalutamide) and is good for use only with a valid prescription for the XTANDI tablet formulation. The Program is not valid for patients whose prescription claims are reimbursed, in whole or in part, by any state or federal government program, including, but not limited to, Medicaid, Medicare, Medigap, Department of Defense (DoD), Veterans Affairs (VA), TRICARE, Puerto Rico Government Insurance, or any state patient or pharmaceutical assistance program.”

Source: [XTANDI: XTANDI® (enzalutamide) | Support Solutions, captured 2026-11-14](https://www.xtandihcp.com/support/xtandi-support-solutions#:~:text=The%20Program%20is%20for%20eligible,patient%20or%20pharmaceutical%20assistance%20program.)

On the page, select: COST AND COPAY SUPPORT

<a id="xtandi-quick-start"></a>

### Can new Xtandi patients get free drug during an insurance delay?

> “The XTANDI QUICK START+® Program provides a one-time, 14-day supply of XTANDI at no cost to new eligible patients who experience a delay in insurance coverage.
>
> Patient eligibility requirements for this program include but are not limited to:
>
> Have prescription drug insurance
> Be new to XTANDI therapy
> Have experienced an insurance-related access delay
> Have been prescribed XTANDI for an FDA-approved indication
>
> The program offers overnight shipping directly to the patient.”

Source: [XTANDI: XTANDI® (enzalutamide) | Support Solutions, captured 2026-11-14](https://www.xtandihcp.com/support/xtandi-support-solutions#:~:text=The%20XTANDI%20QUICK%20START%2B%C2%AE%20Program,shipping%20directly%20to%20the%20patient.)

On the page, select: XTANDI QUICK START+® PROGRAM

<a id="xtandi-benefits-verification"></a>

### How does Xtandi benefits verification work?

> “XTANDI Support Solutions can assist in the evaluation of a patient's insurance coverage for XTANDI. After performing a benefits verification, we will provide a Benefits Summary that includes:
>
> The patient's insurance coverage requirements for XTANDI
> Requirements for prior authorization, step edit, or other coverage restrictions, if any
> Cost-sharing responsibility, including deductibles, coinsurance or copayment, and out-of-pocket maximums
> A list of specialty pharmacies that participate in your patient's insurance coverage
> Electronic Benefits Verification Process
> Go to XTANDIaccess.com to enroll your patient in XTANDI Support Solutions.
> Electronic Benefits Verification leverages a proprietary network of payers and pharmacy benefit managers to provide fast and comprehensive patient coverage results.
> XTANDI Support Solutions will provide a detailed Benefits Summary that includes contact information for the in-network specialty pharmacy processing your patient's prescription.”

Source: [XTANDI: XTANDI® (enzalutamide) | Support Solutions, captured 2026-11-14](https://www.xtandihcp.com/support/xtandi-support-solutions#:~:text=XTANDI%20Support%20Solutions%20can%20assist,pharmacy%20processing%20your%20patient%27s%20prescription.)

On the page, select: ELECTRONIC BENEFITS VERIFICATION

## Cost and coverage

<a id="xtandi-medicare-coverage"></a>

### Is Xtandi covered by Medicare Part D?

> “~99<sup>%</sup>
> of Medicare Part D patients with nmCSPC with high-risk BCR, mCSPC, or CRPC have access to XTANDI*<sup>1</sup>”

Source: [XTANDI: XTANDI® (enzalutamide), captured 2026-11-13](https://www.xtandihcp.com/support/resources-cost-and-coverage#:~:text=of%20Medicare%20Part%20D%20patients,or%20CRPC%20have%20access%20to)

> “*XTANDI national Medicare coverage status as of May 2026. Percentage is rounded to the nearest whole number and represents the percentage of patients with access to XTANDI as a parity or preferred option for the treatment of CSPC or CRPC.”

Source: [XTANDI: XTANDI® (enzalutamide), captured 2026-11-13](https://www.xtandihcp.com/support/resources-cost-and-coverage#:~:text=%2AXTANDI%20national%20Medicare%20coverage%20status,treatment%20of%20CSPC%20or%20CRPC.)

> “The information provided is not a guarantee of coverage of payment (partial or full) and is subject to change without notice.”

Source: [XTANDI: XTANDI® (enzalutamide), captured 2026-11-13](https://www.xtandihcp.com/support/resources-cost-and-coverage#:~:text=The%20information%20provided%20is%20not,subject%20to%20change%20without%20notice.)

Note: The figure covers Medicare Part D patients across every approved use of Xtandi (nmCSPC with high-risk BCR, mCSPC, or CRPC) combined; the page gives no CRPC-only figure. It is the manufacturer's statement of Medicare coverage as of May 2026, on the cost and coverage page captured November 13, 2026.

<a id="xtandi-commercial-coverage"></a>

### Do most Medicare and commercial patients have parity or preferred access to Xtandi?

> “The majority of Medicare and commercial patients have parity
> or preferred access to XTANDI for CRPC and CSPC<sup>†‡1</sup>”

Source: [XTANDI: XTANDI® (enzalutamide), captured 2026-11-13](https://www.xtandihcp.com/support/resources-cost-and-coverage#:~:text=The%20majority%20of%20Medicare%20and,to%20XTANDI%20for%20CRPC%20and)

> “<sup>†</sup>Data are provided by Managed Markets Insight & Technology, LLC and are current as of May 2026.<sup>1</sup>
>
> <sup>‡</sup>Parity indicates that there are no step therapy requirements for XTANDI. Preferred indicates that XTANDI is covered without prior indication-specific therapy requirements and prior trial with XTANDI may be required before other branded therapies are covered.”

Source: [XTANDI: XTANDI® (enzalutamide), captured 2026-11-13](https://www.xtandihcp.com/support/resources-cost-and-coverage#:~:text=are%20provided%20by%20Managed%20Markets,other%20branded%20therapies%20are%20covered.)

> “<sup>§</sup>Check with your individual benefit for plan-specific coverage, prior authorization criteria, step edits, and other possible restrictions.”

Source: [XTANDI: XTANDI® (enzalutamide), captured 2026-11-13](https://www.xtandihcp.com/support/resources-cost-and-coverage#:~:text=with%20your%20individual%20benefit%20for,edits%2C%20and%20other%20possible%20restrictions.)

Note: The statement combines Medicare and commercial patients and covers every approved use of Xtandi (CRPC and CSPC); the page gives no commercial-only or CRPC-only figure. It is the manufacturer's statement, based on Managed Markets Insight & Technology data as of May 2026, on the cost and coverage page captured November 13, 2026.

<a id="xtandi-assistance-program-tablets"></a>

### Which Xtandi forms are available through the Astellas Patient Assistance Program?

> “(Note to Prescriber: Only tablets are available through the Astellas Patient Assistance Program.)”

Source: [XTANDI: XTANDI Support Solutions® Patient Enrollment Form, page 2, captured 2026-11-13](https://www.xtandihcp.com/files/XSS_Patient_Enrollment_Form.pdf#page=2)

Note: The statement is from the prescription section of the XTANDI Support Solutions enrollment form dated 08/23, linked from the support solutions page captured November 13, 2026.

<a id="xtandi-assistance-program-eligibility"></a>

### What affects eligibility for the Astellas Patient Assistance Program for Xtandi?

> “If an application is submitted to determine my eligibility for assistance from the Astellas 
> Patient Assistance Program (PAP), I agree to allow Company and Service Providers to 
> use my demographic information, including, but not limited to, Social Security number, 
> date of birth, name, and/or address as needed to access my credit information and 
> information derived from public and other sources, including information from a consumer 
> reporting agency (credit bureau), to estimate my income in conjunction with the eligibility 
> determination process performed to determine my eligibility under the PAP.”

Source: [XTANDI: XTANDI Support Solutions® Patient Enrollment Form, page 4, captured 2026-11-13](https://www.xtandihcp.com/files/XSS_Patient_Enrollment_Form.pdf#page=4)

> “I agree to notify my healthcare providers and XTANDI Support Solutions if I become 
> aware of changes that would affect my eligibility, including, but not limited to, changes in 
> health insurance status or coverage, financial status, and United States residency.”

Source: [XTANDI: XTANDI Support Solutions® Patient Enrollment Form, page 4, captured 2026-11-13](https://www.xtandihcp.com/files/XSS_Patient_Enrollment_Form.pdf#page=4)

> “I understand that Astellas reserves the right to change or terminate the Astellas Patient 
> Assistance Program at any time, or to refuse to provide XTANDI<sup>®</sup> (enzalutamide) under the 
> Astellas Patient Assistance Program to any patient.”

Source: [XTANDI: XTANDI Support Solutions® Patient Enrollment Form, page 6, captured 2026-11-13](https://www.xtandihcp.com/files/XSS_Patient_Enrollment_Form.pdf#page=6)

Note: These passages are from the patient authorization and prescriber certification statements of the XTANDI Support Solutions enrollment form dated 08/23. The captured content does not state the income or other thresholds the program applies.

<a id="xtandi-copay-program"></a>

### Is there an Xtandi copay savings program?

> “The XTANDI Patient Savings Program* is for eligible commercially insured patients taking XTANDI tablets. The Program parameters are as follows:
>
> Patients may pay as little as $0 per prescription
> Patients will be enrolled in the Program for a 12-month period
> There are no income requirements
> There is a maximum copay assistance limit of $15,000 per calendar year<sup>†</sup>”

Source: [XTANDI: XTANDI® (enzalutamide) | Support Solutions, captured 2026-11-14](https://www.xtandihcp.com/support/xtandi-support-solutions#:~:text=The%20XTANDI%20Patient%20Savings%20Program%2A,limit%20of%20%2415%2C000%20per%20calendar)

On the page, select: COST AND COPAY SUPPORT

> “Eligibility restrictions, terms, and conditions apply.”

Source: [XTANDI: XTANDI® (enzalutamide) | Support Solutions, captured 2026-11-14](https://www.xtandihcp.com/support/xtandi-support-solutions#:~:text=Eligibility%20restrictions%2C%20terms%2C%20and%20conditions%20apply.)

On the page, select: COST AND COPAY SUPPORT

> “The Program is for eligible patients with commercial prescription insurance coverage for XTANDI® (enzalutamide) and is good for use only with a valid prescription for the XTANDI tablet formulation. The Program is not valid for patients whose prescription claims are reimbursed, in whole or in part, by any state or federal government program, including, but not limited to, Medicaid, Medicare, Medigap, Department of Defense (DoD), Veterans Affairs (VA), TRICARE, Puerto Rico Government Insurance, or any state patient or pharmaceutical assistance program.”

Source: [XTANDI: XTANDI® (enzalutamide) | Support Solutions, captured 2026-11-14](https://www.xtandihcp.com/support/xtandi-support-solutions#:~:text=The%20Program%20is%20for%20eligible,patient%20or%20pharmaceutical%20assistance%20program.)

On the page, select: COST AND COPAY SUPPORT

> “This offer is not valid for cash paying patients.”

Source: [XTANDI: XTANDI® (enzalutamide) | Support Solutions, captured 2026-11-14](https://www.xtandihcp.com/support/xtandi-support-solutions#:~:text=This%20offer%20is%20not%20valid%20for%20cash%20paying%20patients.)

On the page, select: COST AND COPAY SUPPORT

> “<sup>†</sup>Subject to a maximum copay assistance limit of $15,000 per calendar year. Unless prohibited by law, Astellas may reduce the cost-sharing assistance available under the Program to a per claim maximum of $25 if it determines a claim for an enrolled patient is subject to a “maximizer” or “accumulator” program.”

Source: [XTANDI: XTANDI® (enzalutamide) | Support Solutions, captured 2026-11-14](https://www.xtandihcp.com/support/xtandi-support-solutions#:~:text=to%20a%20maximum%20copay%20assistance,a%20%E2%80%9Cmaximizer%E2%80%9D%20or%20%E2%80%9Caccumulator%E2%80%9D%20program.)

On the page, select: COST AND COPAY SUPPORT

<a id="xtandi-copay-medicare"></a>

### Can Medicare patients use the Xtandi copay program?

> “The Program is for eligible patients with commercial prescription insurance coverage for XTANDI® (enzalutamide) and is good for use only with a valid prescription for the XTANDI tablet formulation. The Program is not valid for patients whose prescription claims are reimbursed, in whole or in part, by any state or federal government program, including, but not limited to, Medicaid, Medicare, Medigap, Department of Defense (DoD), Veterans Affairs (VA), TRICARE, Puerto Rico Government Insurance, or any state patient or pharmaceutical assistance program.”

Source: [XTANDI: XTANDI® (enzalutamide) | Support Solutions, captured 2026-11-14](https://www.xtandihcp.com/support/xtandi-support-solutions#:~:text=The%20Program%20is%20for%20eligible,patient%20or%20pharmaceutical%20assistance%20program.)

On the page, select: COST AND COPAY SUPPORT

> “Patients who move from commercial insurance to federal or state health insurance will no longer be eligible, and agree to notify the Program of any such change.”

Source: [XTANDI: XTANDI® (enzalutamide) | Support Solutions, captured 2026-11-14](https://www.xtandihcp.com/support/xtandi-support-solutions#:~:text=Patients%20who%20move%20from%20commercial,Program%20of%20any%20such%20change.)

On the page, select: COST AND COPAY SUPPORT

Note: The same support solutions page describes the Astellas Patient Assistance Program and offers information on Medicare Part D Extra Help.

<a id="xtandi-copay-annual-maximum"></a>

### What is the annual maximum of the Xtandi copay program?

> “The Program has a maximum copay assistance limit of $15,000 per calendar year. After the annual maximum on copay assistance is reached, patient will be responsible for the remaining out-of-pocket costs for XTANDI.”

Source: [XTANDI: XTANDI® (enzalutamide) | Support Solutions, captured 2026-11-14](https://www.xtandihcp.com/support/xtandi-support-solutions#:~:text=The%20Program%20has%20a%20maximum,remaining%20out%2Dof%2Dpocket%20costs%20for%20XTANDI.)

On the page, select: COST AND COPAY SUPPORT

> “The Program is for eligible patients with commercial prescription insurance coverage for XTANDI® (enzalutamide) and is good for use only with a valid prescription for the XTANDI tablet formulation. The Program is not valid for patients whose prescription claims are reimbursed, in whole or in part, by any state or federal government program, including, but not limited to, Medicaid, Medicare, Medigap, Department of Defense (DoD), Veterans Affairs (VA), TRICARE, Puerto Rico Government Insurance, or any state patient or pharmaceutical assistance program.”

Source: [XTANDI: XTANDI® (enzalutamide) | Support Solutions, captured 2026-11-14](https://www.xtandihcp.com/support/xtandi-support-solutions#:~:text=The%20Program%20is%20for%20eligible,patient%20or%20pharmaceutical%20assistance%20program.)

On the page, select: COST AND COPAY SUPPORT

> “<sup>†</sup>Subject to a maximum copay assistance limit of $15,000 per calendar year. Unless prohibited by law, Astellas may reduce the cost-sharing assistance available under the Program to a per claim maximum of $25 if it determines a claim for an enrolled patient is subject to a “maximizer” or “accumulator” program.”

Source: [XTANDI: XTANDI® (enzalutamide) | Support Solutions, captured 2026-11-14](https://www.xtandihcp.com/support/xtandi-support-solutions#:~:text=to%20a%20maximum%20copay%20assistance,a%20%E2%80%9Cmaximizer%E2%80%9D%20or%20%E2%80%9Caccumulator%E2%80%9D%20program.)

On the page, select: COST AND COPAY SUPPORT

<a id="xtandi-copay-accumulator"></a>

### Does the Xtandi copay program work with accumulator or maximizer plans?

> “Astellas may reduce or discontinue the copay assistance available under the Program if it determines an enrolled patient is subject to a program offered by a third-party payer or pharmacy benefit manager, or an agent of either, that adjusts patients' out-of-pocket cost-sharing obligations based on the copay assistance provided by this Program, or excludes the copay assistance provided under this Program from counting towards an enrolled patient's out-of-pocket cost-sharing obligations (“maximizer” or “accumulator” program). The Program uses advanced logic to identify whether a claim for an enrolled patient is subject to a “maximizer” or “accumulator” program. Unless prohibited by law, Astellas may reduce the cost-sharing assistance available under the Program to a per claim maximum of $25 if it determines a claim for an enrolled patient is subject to a “maximizer” or “accumulator” program.”

Source: [XTANDI: XTANDI® (enzalutamide) | Support Solutions, captured 2026-11-14](https://www.xtandihcp.com/support/xtandi-support-solutions#:~:text=Astellas%20may%20reduce%20or%20discontinue,enrolled%20patient%20is%20subject%20to%20a%20%E2%80%9Cmaximizer%E2%80%9D%20or%20%E2%80%9Caccumulator%E2%80%9D%20program.)

On the page, select: COST AND COPAY SUPPORT

> “The Program is for eligible patients with commercial prescription insurance coverage for XTANDI® (enzalutamide) and is good for use only with a valid prescription for the XTANDI tablet formulation. The Program is not valid for patients whose prescription claims are reimbursed, in whole or in part, by any state or federal government program, including, but not limited to, Medicaid, Medicare, Medigap, Department of Defense (DoD), Veterans Affairs (VA), TRICARE, Puerto Rico Government Insurance, or any state patient or pharmaceutical assistance program.”

Source: [XTANDI: XTANDI® (enzalutamide) | Support Solutions, captured 2026-11-14](https://www.xtandihcp.com/support/xtandi-support-solutions#:~:text=The%20Program%20is%20for%20eligible,patient%20or%20pharmaceutical%20assistance%20program.)

On the page, select: COST AND COPAY SUPPORT

<a id="xtandi-patient-assistance-program"></a>

### Is there an Xtandi patient assistance program for uninsured patients?

> “Astellas PAP provides XTANDI at no cost to patients who meet the program eligibility requirements. Eligibility is determined on a patient-specific basis. XTANDI Support Solutions can quickly confirm whether your patient is eligible and answer any questions you may have.
>
> Your patients may be eligible for this program if they:
>
> Are uninsured; a patient is considered uninsured when a patient has no prescription drug insurance<sup>†</sup>
> Have a verifiable shipping address in the United States
> Have been prescribed XTANDI for an FDA-approved indication
> Meet the program financial eligibility requirements”

Source: [XTANDI: XTANDI® (enzalutamide) | Support Solutions, captured 2026-11-14](https://www.xtandihcp.com/support/xtandi-support-solutions#:~:text=Astellas%20PAP%20provides%20XTANDI%20at,the%20program%20financial%20eligibility%20requirements)

On the page, select: ASTELLAS PATIENT ASSISTANCE PROGRAM (PAP)*

> “*Subject to meeting eligibility requirements. Void where prohibited by law.”

Source: [XTANDI: XTANDI® (enzalutamide) | Support Solutions, captured 2026-11-14](https://www.xtandihcp.com/support/xtandi-support-solutions#:~:text=%2ASubject%20to%20meeting%20eligibility%20requirements.%20Void%20where%20prohibited%20by%20law.)

On the page, select: ASTELLAS PATIENT ASSISTANCE PROGRAM (PAP)*

> “<sup>†</sup>Other insured patients may be eligible for the program if they meet certain eligibility criteria.”

Source: [XTANDI: XTANDI® (enzalutamide) | Support Solutions, captured 2026-11-14](https://www.xtandihcp.com/support/xtandi-support-solutions#:~:text=insured%20patients%20may%20be%20eligible,they%20meet%20certain%20eligibility%20criteria.)

On the page, select: ASTELLAS PATIENT ASSISTANCE PROGRAM (PAP)*

Note: The page does not state the financial eligibility thresholds of the Astellas Patient Assistance Program.

<a id="xtandi-medicare-extra-help"></a>

### Does Xtandi Support Solutions offer information on Medicare Extra Help?

> “XTANDI Support Solutions also offers information about other assistance options, such as Medicare Part D Extra Help.”

Source: [XTANDI: XTANDI® (enzalutamide) | Support Solutions, captured 2026-11-14](https://www.xtandihcp.com/support/xtandi-support-solutions#:~:text=XTANDI%20Support%20Solutions%20also%20offers,Medicare%20Part%20D%20Extra%20Help.)

On the page, select: INFORMATION ABOUT OTHER ASSISTANCE OPTIONS

> “Extra Help is a program to help eligible people pay Medicare Part D
> prescription drug costs, including premiums, deductibles, and coinsurance.”

Source: [XTANDI: XTANDI® (enzalutamide) | Support Solutions, captured 2026-11-14](https://www.xtandihcp.com/support/xtandi-support-solutions#:~:text=Extra%20Help%20is%20a%20program,including%20premiums%2C%20deductibles%2C%20and%20coinsurance.)

On the page, select: INFORMATION ABOUT OTHER ASSISTANCE OPTIONS

## Prior authorization

<a id="xtandi-prior-authorization"></a>

### What resources help with Xtandi prior authorization?

> “The following resources may help providers obtain prior authorization from a patient's insurance company or respond to a denied claim.
>
> Sample Letter of Medical Necessity Template
>
> When seeking prior authorization, HCPs can refer to this sample letter that shows how to explain why a patient needs a particular treatment.”

Source: [XTANDI: XTANDI® (enzalutamide) | Access and Support Resources, captured 2026-11-13](https://www.xtandihcp.com/support/access-support#:~:text=The%20following%20resources%20may%20help,patient%20needs%20a%20particular%20treatment.)

<a id="xtandi-denial-appeal"></a>

### How can offices appeal an Xtandi insurance denial?

> “Sample Letter of Denial Appeal Template
>
> When appealing a denial for coverage, HCPs can refer to this sample letter that shows how to request a reconsideration.”

Source: [XTANDI: XTANDI® (enzalutamide) | Access and Support Resources, captured 2026-11-13](https://www.xtandihcp.com/support/access-support#:~:text=Sample%20Letter%20of%20Denial%20Appeal,how%20to%20request%20a%20reconsideration.)

<a id="xtandi-prior-authorization-support"></a>

### How does Xtandi Support Solutions help with prior authorization?

> “XTANDI Support Solutions can assist when a patient's insurer requires prior authorization (PA) approval.
>
> Prior Authorization Assistance Process
> XTANDI Support Solutions will identify PA requirements, if any, and triage the patient's case to the network specialty pharmacy. The specialty pharmacy will initiate and support the PA.
> XTANDI Support Solutions will follow up with the specialty pharmacy to track the patient's status and provide support as needed.
> XTANDI Support Solutions will notify you of the outcome.”

Source: [XTANDI: XTANDI® (enzalutamide) | Support Solutions, captured 2026-11-14](https://www.xtandihcp.com/support/xtandi-support-solutions#:~:text=XTANDI%20Support%20Solutions%20can%20assist,notify%20you%20of%20the%20outcome.)

On the page, select: PRIOR AUTHORIZATION ASSISTANCE

> “If the patient's insurance denies a prior authorization (PA) request, XTANDI Support Solutions can assist the HCP with an appeal.
>
> Prior Authorization Denial Appeal Process
> We will determine if any additional documentation is required by the patient's insurer.
> We will inform the HCP of what information is needed and how to provide it to the insurer.
> We will track and inform the HCP of the appeal status.”

Source: [XTANDI: XTANDI® (enzalutamide) | Support Solutions, captured 2026-11-14](https://www.xtandihcp.com/support/xtandi-support-solutions#:~:text=If%20the%20patient%27s%20insurance%20denies,HCP%20of%20the%20appeal%20status.)

This passage is in a collapsed section of the page; select: PRIOR AUTHORIZATION DENIAL APPEALS

## Patient support

<a id="xtandi-support-solutions"></a>

### What is Xtandi Support Solutions?

> “XTANDI Support Solutions* offers access and reimbursement support to help patients access XTANDI. XTANDI Support Solutions provides information regarding patient healthcare coverage, financial assistance options that may be available to help patients with financial needs, and HCP support on matters related to access and reimbursement.”

Source: [XTANDI: XTANDI® (enzalutamide) | Support Solutions, captured 2026-11-14](https://www.xtandihcp.com/support/xtandi-support-solutions#:~:text=XTANDI%20Support%20Solutions%2A%20offers%20access,related%20to%20access%20and%20reimbursement.)

> “1-855-8XTANDI (855-898-2634), Monday–Friday, 8:00 AM–8:00 PM ET”

Source: [XTANDI: XTANDI® (enzalutamide) | Support Solutions, captured 2026-11-14](https://www.xtandihcp.com/support/xtandi-support-solutions#:~:text=1%2D855%2D8XTANDI%20%28855%2D898%2D2634%29%2C%20Monday%E2%80%93Friday%2C%208%3A00%20AM%E2%80%938%3A00%20PM%20ET)

> “The HCP office has access to an ARM who can provide education on matters related to access and reimbursement. Your XTANDI Sales Representative can provide you with the ARM's contact information.”

Source: [XTANDI: XTANDI® (enzalutamide) | Support Solutions, captured 2026-11-14](https://www.xtandihcp.com/support/xtandi-support-solutions#:~:text=The%20HCP%20office%20has%20access,with%20the%20ARM%27s%20contact%20information.)

> “*XTANDI Support Solutions is a component of Astellas Pharma Support Solutions<sup>SM</sup>. Terms and conditions apply.”

Source: [XTANDI: XTANDI® (enzalutamide) | Support Solutions, captured 2026-11-14](https://www.xtandihcp.com/support/xtandi-support-solutions#:~:text=%2AXTANDI%20Support%20Solutions%20is%20a,Terms%20and%20conditions%20apply.)

<a id="xtandi-enroll-support-solutions"></a>

### How do you enroll a patient in Xtandi Support Solutions?

> “Once your patient has been prescribed XTANDI, you can help them access 
> XTANDI by enrolling them in XTANDI Support Solutions.
> Once they are enrolled, XTANDI Support Solutions can help patients 
> navigate the reimbursement process and evaluate their eligibility for 
> financial assistance.
> Quickly Enroll Patients Online
> Go to XTANDIaccess.com to get started.”

Source: [XTANDI: Getting_Started_with_XtandiAccess_Flashcard.pdf, page 1, captured 2026-11-13](https://www.xtandihcp.com/files/Getting_Started_with_XtandiAccess_Flashcard.pdf#page=1)

> “You will need the following information ready to complete                
> patient enrollment:
> •	 Office contact phone number
> •	 Patient’s pharmacy insurance information
> •	 Patient’s name, date of birth, address, phone number, and 
> email address”

Source: [XTANDI: Getting_Started_with_XtandiAccess_Flashcard.pdf, page 1, captured 2026-11-13](https://www.xtandihcp.com/files/Getting_Started_with_XtandiAccess_Flashcard.pdf#page=1)

> “To quickly enroll your patients in XTANDI Support Solutions, visit XTANDIAccess.com”

Source: [XTANDI: XTANDI® (enzalutamide) | Support Solutions, captured 2026-11-14](https://www.xtandihcp.com/support/xtandi-support-solutions#:~:text=To%20quickly%20enroll%20your%20patients%20in%20XTANDI%20Support%20Solutions%2C%20visit%20XTANDIAccess.com)

<a id="xtandi-patient-connect"></a>

### Can Xtandi Patient Connect help patients find emotional or transportation support?

> “XTANDI Patient Connect helps connect patients and their caregivers to independent resources and third-party support services that may help them manage their disease and daily life while on treatment. XTANDI Patient Connect resources offer emotional, logistical, and informational support.*
>
> When a patient or caregiver calls XTANDI Support Solutions, a trained representative will assess their specific needs and will conduct a search of various independent local and national organizations* that may provide the support and resources requested.
>
> The patient or caregiver will be able to contact those providers to enroll or engage in those services.
>
> Resources provided by third-party organizations may include:
>
> Emotional Support
> Connecting patients to social workers, counseling services, or online communities
> Emotional support for the caregiver
> Logistical Support
> Transportation and lodging assistance for treatment
> Help with other day-to-day tasks
> Informational Support
> Education and resources
> Advice and recommendations on nutrition and self-care”

Source: [XTANDI: XTANDI® (enzalutamide) | Support Solutions, captured 2026-11-14](https://www.xtandihcp.com/support/xtandi-support-solutions#:~:text=XTANDI%20Patient%20Connect%20helps%20connect,recommendations%20on%20nutrition%20and%20self%2Dcare)

This passage is in a collapsed section of the page; select: XTANDI PATIENT CONNECT

> “*Support is provided through third-party organizations that operate independently and are not controlled or endorsed by Astellas. Availability of support and eligibility requirements are determined by these organizations.”

Source: [XTANDI: XTANDI® (enzalutamide) | Support Solutions, captured 2026-11-14](https://www.xtandihcp.com/support/xtandi-support-solutions#:~:text=%2ASupport%20is%20provided%20through%20third%2Dparty,are%20determined%20by%20these%20organizations.)

This passage is in a collapsed section of the page; select: XTANDI PATIENT CONNECT

## Related pages
- [Medical information: Xtandi (enzalutamide): All indications](https://www.evicenter.com/medical-information/xtandi)
- [Indication](https://www.evicenter.com/medical-information/xtandi/indication)
- [Pharmacology](https://www.evicenter.com/medical-information/xtandi/pharmacology)
- [Safety](https://www.evicenter.com/medical-information/xtandi/safety)
- [Specific populations](https://www.evicenter.com/medical-information/xtandi/specific-populations)
- [Drug interactions](https://www.evicenter.com/medical-information/xtandi/drug-interactions)
- [Dosing and administration](https://www.evicenter.com/medical-information/xtandi/dosing-and-administration)
- [Storage and supply](https://www.evicenter.com/medical-information/xtandi/storage-and-supply)
